SCHEMBL5798648

SCHEMBL5798648

COc1cc(SS)cc(OC)c1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.52
▸ MAPT P10636 3/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CA9 Q16790 1/20 0.50
▸ PTGS2 P35354 1/20 0.46
▸ CYP1A1 P04798 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP1B1 Q16678 2/20 0.43
▸ HTR2A P28223 1/20 0.42
▸ HTR2C P28335 1/20 0.42
▸ HTR2B P41595 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ LMNA P02545 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TUBB4A P04350 3/20 0.40
▸ TUBB P07437 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5094631 0.80 ACHE (0.56) ACHEMAPTCYP3A4CA9PTGS2
SCHEMBL2545682 0.80 ACHE (0.56) ACHEMAPTCYP3A4CA9PTGS2
SCHEMBL7911729 0.78 CYP1A1 (0.58) ACHEMAPTCYP3A4CA9PTGS2
SCHEMBL8428069 0.76 ACHE (0.52) ACHEMAPTCYP3A4CA9PTGS2
SCHEMBL5094630 0.76 ACHE (0.52) ACHEMAPTCYP3A4CA9PTGS2
SCHEMBL18593938 0.76 ACHE (0.52) ACHEMAPTCYP3A4CA9PTGS2
SCHEMBL6335640 0.74 CA2 (0.48) ACHEMAPTCYP3A4CA9CYP1A2
SCHEMBL8351063 0.73 PTGS2 (0.54) ACHEMAPTCYP3A4CA9PTGS2
SCHEMBL1337937 0.72 ACHE (0.59) ACHEMAPTCYP3A4CA9PTGS2
SCHEMBL9111455 0.71 PTGS2 (0.47) ACHEMAPTCYP3A4CA9PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006041961-A1 ARYLTHIOINDOLE TUBULIN POLYMERIZATION INHIBITORS AND METHODS OF TREATING OR PREVENTING CANCER USING SAME GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTHAND HUMAN SERVICES (US) 2006-04-20 — — WO disclosed
Send feedback